Schedule III for Cannabis Operators: 280E Relief, Banking Reality, and What Dispensary Owners Should Do Now

TL;DR: On April 22, 2026, state-licensed medical marijuana moved to Schedule III of the Controlled Substances Act, ending the application of IRS Section 280E for qualifying medical operators. Treasury's announced transition rule generally applies the relief across the full taxable year that includes the effective date, meaning calendar-year medical operators can plan on a clean 2026. Banking restrictions are not resolved by rescheduling and still require congressional action.

If you own or operate a state-licensed medical cannabis business in the United States, your tax life officially changed on April 22, 2026. Whether your banking life changed is a much more complicated question, and worth getting honest about before any of us start measuring drapes.

Last week we walked through what the DOJ's rescheduling order means for everyone. This piece is for the operators, the CFOs, the founders who have spent the last decade running profitable businesses that looked underwater on paper because of a 1982 tax provision that should never have applied to a legal industry. Here's what just changed, what hasn't, and what you should already be doing about it.

What Changed for Cannabis Operators on April 22, 2026?

State-licensed medical marijuana moved from Schedule I to Schedule III of the Controlled Substances Act, which ends Section 280E's application to qualifying medical operations. Adult-use cannabis remained in Schedule I. The DOJ's final order also creates an expedited DEA registration pathway for state-licensed medical operators.

The change is narrow, conditional, and operationally significant. Here's a side-by-side of what the order actually moved versus what it left behind:

What Is Section 280E and Why Does Rescheduling End It for Medical Operators?

Section 280E is an IRS code provision that disallows ordinary business deductions and credits for any business "trafficking" in Schedule I or II controlled substances. It applies only to those two schedules. State-licensed medical marijuana is now Schedule III, so 280E no longer applies to those operations.

For 44 years, 280E has been the single biggest tax penalty in the legal cannabis economy. Rent, payroll, marketing, professional fees, and most other operating expenses have been off the table for deduction. Only cost of goods sold has been allowed.

According to industry estimates cited by NPR and multiple cannabis-specialized law firms tracking the industry, this has historically pushed effective federal tax rates into the 70 to 80 percent range for retail-heavy operators. The DOJ's final order explicitly acknowledges the consequence, stating that state licensees will no longer be subject to the 280E deduction disallowance.

For a medical-only operator, that means rent, payroll, marketing, software, and professional services are deductible again under standard Section 162 treatment. The same way every other legal business in America gets to operate.

When Does 280E Relief Actually Take Effect?

For most calendar-year medical operators, 280E relief applies to the entire 2026 tax year, not just the period after April 22. Treasury and the IRS announced on April 23, 2026 that forthcoming guidance will include a transition rule applying rescheduling across the full taxable year that contains the effective date.

That's a meaningful difference from the alternative scenario, where 280E would have stopped applying only for tax years beginning after the close of your 2026 tax year. Under that "deferred rescheduling" approach, calendar-year operators would have waited until 2027 for any benefit.

A few important caveats:

• This is the announced framework, not a final regulation
• "Generally" is doing some work in Treasury's language, and edge cases exist
• The DOJ order itself states that nothing in the rule constitutes a determination regarding federal tax liability

For planning purposes, calendar-year medical operators should be modeling 2026 as a fully deductible year. Don't, however, cut payroll bonus checks against your projected savings before the formal IRS guidance lands.

Will the IRS Provide Retroactive 280E Relief for Prior Tax Years?

Retroactive relief is encouraged in the DOJ order but not mandated, and Treasury has not committed to providing it. Any retroactive component would be limited by the standard three-year statute of limitations on amended returns and would require formal IRS action.

The DOJ order goes out of its way to encourage Treasury to consider providing retrospective relief from Section 280E for tax years in which a state licensee operated under a state medical marijuana license. That's a green light, not a directive.

What this could mean if Treasury runs with it:

• Eligible medical operators could potentially file amended returns or protective claims for prior years
• The window would be limited to the three-year statute of limitations on amended returns
• The exposure cuts both ways. Any operator who pursues this path is essentially asking the IRS to revisit prior returns, which can carry audit risk on other items

Tax attorneys are split on the wisdom of jumping early. Some are advising clients to file 2025 returns without 280E or pursue amended returns now. Others are warning that this path leads directly to tax court if the IRS doesn't actually issue retroactive guidance. Talk to a cannabis-specialized CPA before filing anything aggressive.

How Does Rescheduling Affect Dual-License Cannabis Operators?

Dual-license operators must apportion expenses between medical operations (no longer subject to 280E) and adult-use operations (still subject to 280E). Treasury's announced guidance will clarify that 280E applies only to the activities related to Schedule I or II trafficking, generally through expense apportionment.

This is the part the multistate operators and dual-license dispensaries need to think very carefully about. Some questions to work through with your accountant immediately:

• How do you allocate shared facility costs (rent, utilities, security) between medical and adult-use operations?
• How do you split payroll for staff who work across both sides?
• How are you treating shared management, marketing, and professional services?
• How do your existing entity structures hold up under apportionment?

Many operators built complex management company arrangements specifically to manage 280E exposure. For medical-only entities, those structures may now be unnecessary overhead. For dual-license entities, they may need rethinking entirely.

If you don't have clean books separating medical from adult-use already, fix that immediately. The IRS guidance will require it, and the operators who segregated their P&Ls in advance will be in much better shape than the ones who didn't.

How Do I Apply for the New DEA Medical Marijuana Registration?

State-licensed medical operators can apply for federal DEA registration under a new expedited pathway. Applications submitted within 60 days of the order's Federal Register publication receive a six-month target processing window, and early applicants can lawfully operate under their state-issued licenses during the pendency of review.

Key registration facts:

• DEA uses your state license as conclusive evidence of state-law authorization
• Registration covers manufacturers, distributors, and dispensers
• A single entity can hold multiple registration types
• If your state license is suspended, revoked, or expires, your DEA registration is automatically suspended along with it
• DEA registration is not technically required for 280E tax relief
• DEA registration enables the ability to import and export medical marijuana products under federal permit

For most state-licensed medical operators, applying in the early window is the clearer move. The registration also signals federal compliance to lenders and investors.

Does Schedule III Rescheduling Fix Cannabis Banking?

No. Schedule III does not, by itself, fix cannabis banking. Banks operate under Bank Secrecy Act (BSA) and federal anti-money laundering (AML) obligations that require Suspicious Activity Reports on transactions involving funds from federally illegal activity. The Financial Crimes Enforcement Network's (FinCEN) 2014 marijuana banking guidance remains in effect and unchanged.

This is the part nobody wants to tell you about, and it's worth getting straight before you build a 2026 plan around expanded banking access.

According to the Congressional Research Service, as of March 2024, FinCEN had received more than 410,000 marijuana-related SARs from approximately 680 depository institutions filing them. None of that compliance infrastructure is dismantled by rescheduling.

"Cannabis would still be largely illegal under federal law, and that is a line many banks in this country will not cross. The solution is the bipartisan SAFER Banking Act."

American Bankers Association, public statement on cannabis banking and rescheduling

What Banking Changes (Modestly) With Rescheduling

• Political stigma is reduced, and Schedule III feels different than Schedule I to a bank's risk committee
• Operator financial health improves substantially due to 280E relief
• The legal risk picture for serving medical operators is somewhat clearer than for adult-use

What Banking Doesn't Change

• BSA and AML obligations are functionally identical
• FinCEN's 2014 guidance is still operative and still requires marijuana-related SARs
• Visa and Mastercard network rules still disallow cannabis transactions on branded cards
• The cash-heavy nature of dispensary operations is not solved
• Federal mortgage programs (Fannie Mae, Freddie Mac) still treat cannabis-related income as suspect

The structural fix for cannabis banking has always been the SAFER Banking Act, which would create a federal safe harbor for financial institutions serving state-legal cannabis businesses. That bill has stalled in the Senate multiple times, and its passage is independent of rescheduling.

What Should Cannabis Dispensary Owners Do Right Now?

A short, practical action list for state-licensed medical operators in the first 60 days post-rescheduling:

1. Talk to a cannabis-specialized CPA immediately. Not your general business accountant. This requires industry-specific expertise.
2. Model 2026 cash flow with full Section 162 deductions for medical operations. Compare it to your prior 280E-heavy projections.
3. Segregate your books cleanly. If you're dual-license, you need apportionment-ready accounting before IRS guidance lands.
4. Evaluate filing a protective claim for prior years to preserve your rights pending Treasury's decision on retroactive relief.
5. Apply for DEA registration in the first 60-day window to capture the expedited six-month review.
6. Continue applying 280E to all adult-use operations and all pre-April 22, 2026 periods. Maximize allowable cost of goods sold.
7. Review your entity structures. Management company arrangements built around 280E may now be expensive overhead.
8. Watch the June 29 hearing. A broader rescheduling outcome would extend Schedule III to adult-use operations.
9. Watch the litigation. Smart Approaches to Marijuana has announced it will sue to block the order.

What Happens After the June 29, 2026 DEA Hearing?

The DEA's expedited administrative hearing on broader rescheduling begins June 29, 2026, and is scheduled to conclude no later than July 15, 2026. The outcome will determine whether all marijuana, including adult-use, gets moved to Schedule III, or whether the current bifurcated structure remains in place indefinitely.

Two scenarios to plan for:

If broader rescheduling succeeds, Section 280E relief would extend to the entire industry. Banking risk profiles would shift again. Capital markets access would open further. The medical-only carve-out becomes a footnote in a much larger story.

If broader rescheduling fails or gets delayed, the bifurcated structure becomes the operating reality for the foreseeable future. Smart operators are running scenarios for both outcomes.

Frequently Asked Questions

Does the rescheduling order eliminate 280E for adult-use cannabis dispensaries?

No. The April 22, 2026 order moves only state-licensed medical marijuana and FDA-approved marijuana products to Schedule III. Adult-use (recreational) cannabis remains in Schedule I, which means Section 280E continues to disallow ordinary business deductions for adult-use operations. Adult-use operators must wait for the broader rescheduling outcome from the June 29, 2026 DEA hearing.

Can I file an amended return to claim 280E refunds for prior tax years?

Treasury and the IRS have not yet authorized retroactive 280E relief. The DOJ order encourages Treasury to consider it, but no formal mechanism exists yet. Filing aggressive amended returns now risks an IRS dispute. A protective claim, which preserves your statute-of-limitations rights without demanding an immediate refund, is a more conservative option that some tax counsel may recommend depending on your specific situation.

Do I need DEA registration to claim 280E tax relief?

No. DEA registration is not technically a prerequisite for 280E relief, which is determined by the federal scheduling status of your products under the Controlled Substances Act. However, DEA registration enables other benefits, including federal compliance signaling to lenders, the ability to apply for import and export permits, and clearer legal standing under the federal cooperative-federalism framework established by the order.

Will banks start serving cannabis businesses now that rescheduling has happened?

Probably modestly, but not transformatively. Bank Secrecy Act and anti-money laundering obligations are unchanged by rescheduling. FinCEN's 2014 cannabis banking guidance remains in effect. Some smaller banks and credit unions with higher risk appetites may take on more medical operators, but card processing, federal mortgage treatment, and broad financial services access will likely require the SAFER Banking Act or similar congressional action.

When will the IRS issue formal 280E guidance for cannabis operators?

Treasury and the IRS announced on April 23, 2026 that they plan to issue formal guidance, but no specific publication date has been provided. The guidance is expected to address the transition rule, expense apportionment for dual-license businesses, and the framework for state-licensed medical operations going forward. Operators should monitor IRS announcements and consult cannabis-specialized tax counsel for current status.

Does the order affect cannabis businesses operating only in adult-use states with no medical program?

Largely, no. The rescheduling applies to marijuana subject to a qualifying state medical marijuana license. Operators in adult-use-only markets without a corresponding medical license remain fully subject to Section 280E and Schedule I status. The June 29, 2026 hearing is the more relevant proceeding for adult-use operators, since its outcome could extend Schedule III treatment to the broader market.

The Bottom Line

The April 22 rescheduling is the most consequential federal cannabis policy shift in 50 years for state-licensed medical operators. Section 280E, the single biggest financial millstone the industry has carried, is gone for qualifying medical operations. Treasury's transition rule appears generous, applying the change across the full taxable year that includes the effective date. Retroactive relief is on the table but not yet promised.

Banking is a more complicated picture. Rescheduling reduces some friction and improves operator economics, but it does not solve the structural banking problem. That requires Congress.

For dual-license operators, life just got more complicated, not less. For medical-only operators, life just got considerably easier. For everyone, the June 29 hearing will determine whether this is the floor or the ceiling.

We here at Where's Weed will keep you posted as Treasury and IRS guidance drops, as the hearing process plays out, and as the inevitable litigation moves through the courts. In the meantime, talk to your tax counsel, segregate your books, and don't make irreversible business decisions based on commentary that hasn't yet been backed up by formal guidance.

This isn't the finish line. It's the first time the industry has been allowed onto the track.

Last updated: April 25, 2026 | Sources: U.S. Department of Justice Final Order AG No. 6754-2026; U.S. Treasury Press Release SB0471; Congressional Research Service Report LSB11218; American Bankers Association